Cardiac 18f-fdg-spet studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping

Nuclear Medicine Communications

Volumn 18, Issue 3, 1997, Pages 200-206

  Bax, Jeroen J ^a   Visser, F C ^b   Raymakers, P G H M ^b   Van Lingen, A ^b   Huitink, J M ^b   Heine, R J ^b   Visser, C A ^b   Cornel, J H ^c   Elhendy, A ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Medical Centre Alkmaar   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUORODEOXYGLUCOSE F 18; INSULIN; THALLIUM; THALLIUM 201;

AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART; HUMAN; HYPERINSULINISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; HEART FUNCTION; IMAGE QUALITY; POSITRON EMISSION TOMOGRAPHY;

AGED; BLOOD GLUCOSE; CORONARY DISEASE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE CLAMP TECHNIQUE; HEART; HUMANS; HYPERINSULINISM; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030615296     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199703000-00003     Document Type: Article

References (26)

1. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
2. Schelbert HR. Positron emission tomography for the assessment of myocardial viability. Circulation 1991; 84: 122-131.
3. Bax JJ, Visser FC, Blanksma PK et al Comparison of myocardial uptake of, HF-fluorodeoxyglucose imaged with positron emission tomography and single photon emission computed tomography in dyssynergic myocardium. J Nucl Med 1996; 37: 1631-1636.
4. Sandler MP, Videlefsky S, Delbeke D et al Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 870-888.
5. Burt RW, Perkins OW, Oppenheim BE et al Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for the detection of myocardial viability. J Nucl Med 1995; 36: 176-179.
6. Gropler RJ. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose. J Nucl Cardiol 1994; 1: S1-14.
7. Vom Dahl J, Hicks RJ, Lee KS, Eitzman DT, Al-Aouar ZR, Schwaiger M. Positron emission tomography myocardial viability studies in patients with diabetes mellitus. J Am Coll Cardiol 1991; 17: 121A.
8. Bonow RO, Berman DS, Gibbons RJ et al Cardiac positron emission tomography: A report for health professionals from the Committee on Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation 1991; 84: 447-454.
9. Knuuti MJ, Nuutila P, Ruotsalainen U et al Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255-1262.
10. Vom Dahl J, Herman WH, Hicks RJ et al Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 1993; 88: 395-404.
11. Ohtake T, Yokoyama I, Watanabe T et al Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995; 36: 456-463.
12. Melin JA, Becker L. Quantitative relationship between global left ventricular thallium uptake and blood flow: Effects of propranolol, ouabain, dipyridamole and coronary artery occlusion. J Nucl Med 1986; 7: 527-537.
13. Hamacher K, Coenen HH, Stocklin G. Efficient stereo-specific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
14. Phelps ME, Hoffman EJ, Selin C et al. investigation of [18F]2-fluoro-2-deoxyglucose for the measurement of myocardial glucose metabolism. J Nucl Med 1978; 19: 1311-1319.
15. Van Lingen A, Huijgens PC, Visser FC et al. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera. Eur J Nucl Med 1992; 19: 315-321.
16. Bax JJ, Visser FC, van Lingen A et al. Relation between myocardial uptake of thallium-201 chloride and F18-fluorodeoxyglucose imaged with SPECT in normal individuals. Eur j Nucl Med 1995; 22: 56-60.
17. Bax JJ, Cornel JH, Visser FC et al Quantitative analysis of FDG and Tl-201 SPECT for the prediction of functional outcome after revascularization. J Nucl Med 1995; 36: 36.
18. Jaarsma W, Visser CA, Eenige van MJ et al. Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardium. Am J Cardiol 1986; 58: 39-18.
19. Camici P, Ferrannini E, Opie LP. Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography. Progr Cardiovasc Dis 1989; 32: 217-238.
20. Huitink JM, Visser FC, van Leeuwen GJ et al. Influence of high and low plasma insulin levels on the uptake of 18F-FDG in myocardium and femoral muscle as assessed by planar imaging. Eur J Nucl Med 1995; 22: 1141-1148.
21. Gravey WT. Glucose transport and NIDDM. Diabetes Care 1992; 15: 396-417.
22. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. J Am Coll Cardiol 1974; 34: 29-34.
23. Black HR. The coronary artery disease paradox: The role of hyperinsulinemia and insulin resistance and implications for therapy. J Cardiovasc Pharmacol 1990; 15 (suppl. 5): S26-38.
24. Schelbert HR. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography (editorial). J Nucl Med 1992; 33: 1263-1266.
25. Knuuti MJ, Yki-Járvinen H, Voipio-Pulkki LM et al. Enhancement of myocardial [fluorine-18] fluorodeoxyglu-cose uptake by a nicotinic acid derivative. J Nucl Med 1994; 35: 989-998.
26. Musatti L, Maggi E, Moro E et al. Bioavailability and pharmacokinetics of acipimox, a new antilipolytic and hypolipidaemic agent. J hit Med Res 1981; 9: 381-386.